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The discovery of PIEZO proteins has enabled better understanding of how cells respond to mechanical 
force1-3. PIEZOs assemble to form ion channels that link force to cell behaviour via transmembrane 
cation flux1,2,4. Shortly after the initial PIEZO discoveries, associations of PIEZO1 mutations with 
xerocytosis / dehydrated hereditary stomatocytosis (DHS)4-15 and links to malarial resistance were 
suggested16. PIEZO1 channels are now an established feature of red blood cell (RBC) biology where 
they regulate intracellular Ca2+ and cell hydration in coordination with other mechanisms such as the 
Gardos channel17-20. However, studies of PIEZO1 reconstituted in cell lines have suggested that the 
channels activate within milliseconds and then inactivate (desensitize) completely within a few hundred 
milliseconds when rapidly stimulated by increases in membrane tension caused by pulling on the 
membrane or cell deformation via a probe1,4,7,9,18. DHS mutations have been found to slow the fast 
inactivation process, which represents gain-of-function7-9,18. It is, however, unclear how such rapid 
events are relevant to RBC physiology. Moreover, although the available data are limited because of 
the low prevalence of DHS, studies of RBCs from patients suggest sustained channel activity unlike 
that reported for PIEZO1 in cell lines6,10,12,15. Therefore we sought additional understanding through 
electrophysiological analysis of murine RBCs. To mechanically stimulate the channels we applied shear 
stress, a frictional force created physiologically by blood flow. To understand the impact of DHS 
mutation we generated the murine equivalent of one of the first-identified DHS mutations, 
M2225R4,5,8,9. 
 
In mouse PIEZO1, the equivalent of M2225R is M2241R. Molecular modelling and pharmacological 
analysis of overexpressed channels suggested suitability of mouse PIEZO1 as a model for human 
PIEZO1 (Supplemental Results and Figures S1-S2). Furthermore, 8 week-old mice homozygous for 
M2241R (PIEZO1M-R/M-R) (Supplemental Results and Figures S3-S4) displayed features consistent with 
DHS that included stomatocytosis (Supplemental Figure S5), decreased osmotic fragility (Supplemental 
Figure S6), decreased haemoglobin, haematocrit and RBC count (Supplemental Table S1) and increased 
RBC and haemoglobin concentration distribution widths and percentage of reticulocytes (Supplemental 
Table S1). There were no significant changes in spleen weight (Supplemental Figure S7) or liver 
function tests (Supplemental Table S2). There were potential changes in plasma iron and total iron 
binding capacity that did not reach statistical significance but transferrin showed a small significant 
increase (Supplemental Table S2). PIEZO1M-R/M-R mice were born at slightly lower frequency than 
wildtype mice, suggesting a potential deleterious effect, but adult PIEZO1M-R/M-R mice appeared normal 
and body weight gain was not different from wildtype mice (Supplemental Figure S8). However, 
increased spleen weight in PIEZO1M-R/M-R mice at 22 weeks of age suggested the potential for age-
related changes in phenotype (Supplemental Figure S7). All experiments henceforth focussed on mice 
at 8 weeks of age. Heterozygote mice (PIEZO1WT/M-R) showed decrease in osmotic fragility but less 
than for PIEZO1M-R/M-R mice, which suggested intermediate phenotype (Supplemental Figure S6). 
PIEZO1WT/M-R mice were born at the expected Mendelian ratio (Supplemental Figure S8). 
 
To understand the effect of M2241R on channel properties, patch-clamp electrophysiology was applied 
to RBCs freshly isolated from mice. For physiological relevance we first used the perforated-patch 
whole-cell configuration to achieve membrane potential measurements. Resting membrane potential 
data are provided in the Supplemental Information. For most experiments, constant current was injected 
to hyperpolarise RBCs to -80 mV and thereby maximise visibility of PIEZO1-related responses to fluid 
flow of 20 L.s-1, a rate that occurs in mice21. There was a small depolarisation to fluid flow in WT 
RBCs, consistent with the opening of PIEZO1 channels (Figure 1a) (mean data in Figure 1d). The 
depolarisation was sustained for at least 20 s. After flow ceased, membrane potential returned to its 
initial value (Figure 1a, d). Depolarisation tended to be larger in PIEZO1WT/M-R and was larger (P < 
0.05) in PIEZO1M-R/M-R RBCs but the most striking difference was failure to recover after flow ceased 
(Figure 1b, c) (mean data in Figure 1d). To further investigate we switched to voltage-clamp mode. In 
WT RBCs, fluid flow caused inward current as expected, which then decayed slowly after about 10 s 
(Figure 1f) (mean data in Figure 1i). In PIEZO1WT/M-R and PIEZO1M-R/M-R RBCs, the initial response 
was similar to WT except the slow inactivation was mostly absent (Figure 1g, h). Most strikingly there 
was failure of current to recover after cessation of fluid flow (Figure 1g, h) (mean data in Figure 1i). 
GsMTx4, an inhibitor of PIEZO1 channel activity22, abolished all depolarising and inward current 
activities (Figure 1e, j; Supplemental Figures S9 and S10). Intriguingly, wash-out of GsMTx4 from 
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mutant RBCs revealed recover to activity that was more like the activity of WT RBCs than mutant 
RBCs in the absence of toxin, suggesting potential to correct the mutant channel behaviour 
(Supplemental Figures S9 and S10). 
 
To investigate more closely, single channel data were sought by recording from cell-attached membrane 
patches under voltage-clamp and applying short pressure pulses to the patch pipette to increase 
membrane tension. Occasionally there was only one unitary current level, suggesting only one channel 
in the patch (Figures 2a and 2e) but in most cases there were multiple channels (e.g., Figure 2c, g). 
PIEZO1 channels were identified by the signature unitary current amplitude1 (Figure 2b, d, f and 
Supplemental Figure S11). In the WT exemplar shown, activity was evoked by the -80 and -90 mmHg 
pressure pulses but afterwards there were only infrequent openings, suggesting that this channel mostly 
deactivated (Figure 2a). The rarity of channel opening was seen particularly in the amplitude histogram, 
which indicated low frequency at -2.5 pA (channel open) relative to that at -0.5 pA (channel closed) 
(Figure 2b). In contrast, in PIEZO1WT/M-R and PIEZO1M-R/M-R RBCs there was identical unitary current 
amplitude but remarkably higher activity after termination of pressure pulses (Figure 2c-f). Histogram 
analysis highlighted the difference between WT and PIEZO1WT/M-R / PIEZO1M-R/M-R because the 
frequency of open-state activity (e.g., at -2.5, -2.7 and -2.4 pA) was high relative to the closed-state 
frequency (i.e., at -0.5, -0.7 and -0.4 pA) (Figure 2d, f cf Figure 2b). Patches containing multiple 
PIEZO1M-R/M-R channels in the same patch also showed the persistent high activity (Figure 2g). 
Summary analysis of multi-channel activity also supported the conclusion that persistent activity was 
greater in PIEZO1WT/M-R / PIEZO1M-R/M-R (Supplemental Figure S12). Unitary current events were 
abolished by GsMTx4 (Figure 2h). 
 
The data suggest that RBCs provide a special environment for PIEZO1 that disables or greatly slows 
the rapid inactivation mechanism and confers importance of deactivation, which is a different 
mechanism from inactivation. In future studies it will be interesting to determine how the rapid 
inactivation gate is disabled or slowed in RBCs. Our work on endothelial PIEZO1 has suggested 
capability of sphingomyelinase to cause such effect23. Sphingomyelinase is known to regulate RBC 
membrane structure24 and adhesion of eryptotic RBCs to endothelial cells25. It will also be interesting 
to determine the molecular mechanism of deactivation in PIEZO1, its sensitivity to other DHS 
mutations in the RBC context and the potential for correction by small-molecules. Such studies could 
have multiple benefits for better understanding RBC homeostasis and DHS and enable better 
appreciation of the mechanical biology of other blood-borne cells that normally live in an environment 
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Figure 1. Slow kinetics of RBC PIEZO1 and slow recovery of PIEZO1WT/M-R and PIEZO1M-R/M-R. 
(a-c) Membrane potential (Vm) recordings obtained using perforated-patch whole-cell mode applied to 
freshly-isolated RBCs from wildtype (WT) (a), PIEZO1WT/M-R (b) or PIEZO1M-R/M-R mice (c). RBCs 
were exposed to 20 µL.s-1 fluid flow for 20 s as indicated by the shaded areas. (d) Summary data for 
experiments of the type shown in (a-c). Presented is the peak (maximum) change in Vm of WT, 
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PIEZO1WT/M-R and PIEZO1M-R/M-R RBCs after exposure to flow and then the Vm at 1-5 min after flow. 
Averaged data are displayed as mean ± s.d. and each individual data point is shown. WT: n = 20 (max, 
1 min), 16 (2 min), 13 (3 min), 9 (4 and 5 min); PIEZO1WT/M-R: n = 13 (max), 12 (1 min), 11 (2 min), 
10 (3 min), 9 (4 and 5 min); PIEZO1M-R/M-R: n = 14 (max, 1 min), 13 (2 min), 11 (3 min), 9 (4 min), 8 
(5 min). (e) As for (d) except with 2.5 M GsMTx4 in the extracellular solution. WT: n = 5 (max, 1 
min, 2 min, 3 min), 4 (4 min), 3 (5 min); PIEZO1WT/M-R: n = 7 (max, 1 min), 6 (2 min), 4 (3 and 4 min), 
3 (5 min); PIEZO1M-R/M-R: n = 8 (max), 6 (1 min), 5 (2 min), 4 (3 min), 3 (4 and 5 min). (f-h) Ionic 
current recordings obtained using perforated-patch technique in whole-cell voltage-clamp mode applied 
to freshly-isolated RBCs from wildtype (WT) (f), PIEZO1WT/M-R (g) or PIEZO1M-R/M-R mice (h). RBCs 
were exposed to 20 µL.s-1 fluid flow for 20 s as indicated by the shaded areas. Holding voltage was -80 
mV. (i) Summary data for experiments of the type shown in (f-h). Presented is the peak (maximum) 
change in current (I) of WT and PIEZO1M-R/M-R RBCs after exposure to flow and then the I at 1 and 
2 min after flow. Averaged data are displayed as mean ± s.d. and each individual data point is shown. 
WT: n = 23 (max, 1 min), 15 (2 min); PIEZO1WT/M-R; n = 12 (max, 1 min), 10 (2 min); PIEZO1M-R/M-R; 
n = 18 (max), 15 (1 min), 11 (2 min). (j) As for (i) except with 2.5 M GsMTx4 in the extracellular 
solution. WT: n = 5 (max, 1 min, 2 min); PIEZO1WT/M-R: n = 4 (max, 1 min), 3 (2 min); PIEZO1M-R/M-
R: n = 4 (max, 1 min, 2 min). Statistical analysis by one-way ANOVA with Bonferroni's post-hoc test 
indicated: (d, i) significant decay of the WT (P ** <0.01 or *** P < 0.001) but not mutant RBC 
responses; (d) significant increase of the Peak response in PIEZO1M-R/M-R RBCs compared with WT (P 
<0.05); (e) no significant effects of flow in WT or PIEZO1WT/M-R but significant hyperpolarisation at 1 
min compared with Peak in PIEZO1M-R/M-R (P < 0.01); and (j) no significant effects of flow in WT or 







Figure 2. Failure of deactivation in PIEZO1WT/M-R and PIEZO1M-R/M-R single channels. Data are 
for single channel activity measured by cell-attached patch technique applied to freshly-isolated RBCs 
of wildtype (WT) mice (a, b), PIEZO1WT/M-R mice (c, d) and PIEZO1M-R/M-R mice (e-h). A fast pressure-
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clamp system applied brief (200-ms) negative pressure pulses to the patches as indicated below the 
original exemplar current traces (a, c, e, g, h). Dashed horizontal lines indicate current levels for closed 
channels (C) and open channels (O, or O1-4 for multiple channel openings in c and g). Constant voltage 
of +80 mV was applied to the patch pipette. Data in (a) and (e) are considered to be for patches each 
containing only 1 PIEZO1 channel, whereas the patches in (c) and (g) contained multiple PIEZO1 
channels. (b, d, f) Amplitude histogram analysis for the exemplar traces, showing plots of the frequency 
of detection of events (N) at the current amplitudes indicated on the x-axis, where zero current indicates 
no current flowing in the circuit. The closed channel state appears as a small negative current peaking 
at -0.5, -0.7 and -0.4 pA in (b), (d) and (f) respectively. The small amount of open channel activity at -
2.5 pA in (b) is shown expanded in the inset panel (b (i)). Raw data are shown with superimposed 
Gaussian fits in green (WT), blue (PIEZO1WT/M-R) and red (PIEZO1M-R/M-R). Representative of n = 6, n 
= 5 and n = 4 for WT, PIEZO1WT/M-R and PIEZO1M-R/M-R respectively. (h) An exemplar recording from 
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Mouse PIEZO1 channel is similar to human PIEZO1 channel Missing unstructured regions were 
modelled in the 3D structure of the mouse PIEZO1 channel derived by electron microscopy1 and then 
a homology model of the human channel was generated based on the mouse PIEZO1 structure (Figure 
S1a). The channels were similar (Figure S1a). M2225 is situated in the C-terminal Extracellular Domain 
(CED), as indicated by the black dashed boxes in Figure S1a. Overlay of the human and mouse channels 
at this position showed that the channels were almost identical around M2225 (Figure S1b). Moreover, 
the position of the mouse equivalent of M2225R (M2241R) and its nearby residues suggested no 
obvious difference from the human situation (Figure S1b). For contrast, the mouse model is also shown 
for alanine (M2241A) in place of arginine (M2241R). The modelled structures suggest suitability of 
mouse PIEZO1 for understanding the human channel. 
 
Overexpressed mutant mouse PIEZO1 exhibits gain-of-function To further test the suitability of the 
mouse channel we looked for gain-of-function by generating the mutation in mouse PIEZO1 clone and 
overexpressing it in a cell line. A functional test was performed by measuring the intracellular Ca2+ 
concentration and applying the PIEZO1 channel agonist, Yoda1 (Figure S2). M2241R approximately 
doubled the response to 0.3 M Yoda1 and increased the response to 1 M Yoda1 by about 60 % 
(Figure S2). Studies of artificial mutations at position 2241 suggested that it was the switch to a positive 
charge that caused the gain-of-function because mutation to lysine (M2241K) conferred similar increase 
in the Yoda1 response whereas mutation to alanine (M2241A) or glutamic acid (M2241E) failed to 
enhance the response (Figure S2). The data further support use of the mouse channel in understanding 
the impact of the human mutation M2225R. 
 
M2241R mice display features of DHS A mutant mouse was generated in which M2241R occurred 
in the endogenous PIEZO1 channel (Figures S3 and S4). We first studied mice that were homozygote 
for the mutation (PIEZO1M-R/M-R mice) at 8 weeks old. These mice exhibited stomatocytes, which is an 
expected feature of DHS (Figure S5). They also showed reduced osmotic fragility (Figure S6). Mice 
that were heterozygote for the mutation (PIEZO1WT/M-R) had milder but nevertheless significantly 
reduced osmotic fragility (Figure S6). At 8 weeks old, PIEZO1M-R/M-R mice showed a trend towards 
increased weight of the spleen, but it failed to reach statistical significance (Figure S7a). At 22 weeks 
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of age, significant increase in the weight of the spleen became apparent (Figure S7b). PIEZO1WT/M-R 
mice showed the expected Mendelian live-birth ratio of 2:1 compared with wildtype (WT) but there 
were slightly fewer than expected PIEZO1M-R/M-R live births, suggesting a possible negative effect of 
homozygosity (Figure S8a). Comparison of body weight increase in adult WT and PIEZO1M-R/M-R mice 
between 21 and 56 days of age revealed no difference (Figure S8b). Haematological analysis of 8 week-
old PIEZO1M-R/M-R mice revealed some of the expected features of DHS2 (Table S1) as described in the 
main Letter. Liver function tests revealed no difference (Table S2). Iron and total iron binding capacity 
were not significantly different but there appeared to be trends towards increases in these parameters. 
A sensitive transferrin assay revealed a small significant increase in transferrin (Table S2). The data 
suggest that M2241R recapitulates key features of DHS but that there may be age-dependent effects, 
such that studies of older M2241R mice could reveal differences not yet evident in 8 week-old mice. 
 
Resting membrane potential of mutant RBCs is slightly hyperpolarised The resting membrane 
potential of PIEZO1M-R/M-R RBCs was slightly hyperpolarised compared to WT RBCs (mean ± s.d.) at 
-9.8 ± 2.4 mV (n=18, PIEZO1M-R/M-R) compared with -7.5 ± 2.3 mV (n=17, WT) (P < 0.01). 
PIEZO1WT/M-R RBCs were intermediate at -8.0 ± 1.5 mV (n=16) (P = 0.052 compared with PIEZO1M-
R/M-R). Statistical analysis used one-way ANOVA with Bonferroni's post-hoc test. 
 
Wash-out of GsMTx4 reveals wildtype-like properties of mutant RBCs. As indicated in the main 
Letter, wash-out of GsMTx4 from mutant RBCs revealed recover to a type of activity that was more 
like the activity of wildtype RBCs in the absence of toxin, suggesting the potential to correct the mutant 
channel behaviour. The supporting data firstly show the exemplar traces for inhibition of the flow-
evoked depolarisation in the presence of 2.5 M GsMTx4 (Supplemental Figure S9a-c), the mean data 
for which are presented in Figure 1e. It is apparent that the depolarisation was not only prevented by 
GsMTx4 but that a hyperpolarisation was revealed, especially in PIEZO1M-R/M-R RBCs. The 
hyperpolarisation was slower in onset (e.g. Figure S9c) compared with the depolarisation in the absence 
of GsMTx4 (e.g. Figure 1c) and we suggest that this effect was most likely mediated by other ionic 
mechanisms. We studied the effect of washing out GsMTx4 on PIEZO1WT/M-R and PIEZO1M-R/M-R RBCs 
because pilot studies indicated an intriguing response: After wash-out, the flow response of mutant 
RBCs resembled the response of wildtype RBCs in the absence of GsMTx4 because there was 
depolarisation that recovered back to baseline after flow stopped (Figure S9d-f cf Figure 1a, d). Similar 
but even more striking observations were made when membrane current was recorded under voltage-
clamp (Figure S10). GsMTx4 caused the flow response to reverse in polarity, becoming an outward 
current, which was slow to occur and especially obvious after flow had stopped (Figure 1j and Figure 
S10a-c). After wash-out of GsMTx4, flow caused inward current that relaxed back to baseline after 
flow stopped (Figure S10d-f), similar to observations for wildtype RBCs in the absence of GsMTx4 
(Figure 1f, i). The data suggest the possibility to pharmacologically revert mutant channel activity back 
to wildtype-like behaviour. 
 
Channel conductance Unitary current was measured for a range of voltages to generate I-V 
relationships for PIEZO1WT/M-R RBCs. The I-Vs were linear and the indicated unitary conductance was 
25.3 pS, which is expected for PIEZO1 channels (Figure S11). 
 
Multi-channel activity analysis Activity of multi-channel patches was analysed by measuring NPo 
after application of a range of pressure pulses for wildtype, PIEZO1WT/M-R and PIEZO1M-R/M-R RBCs, as 
shown in the exemplar traces of Figure 2. From these data it is apparent that wildtype channels were 
largely closed after the pressure pulse ceased, whereas mutant channels retained activity (Figure S12). 
In the absence of applied pressure, NPo was 0.0079 ± 0.0106 for wildtype (n=6), 0.0100 ± 0.0189 for 
PIEZO1WT/M-R (n=5) and 0.0206 ± 0.0179 for PIEZO1M-R/M-R (n=3). The maximum pressure-evoked 
NPo values were 0.1626 ± 0.2017 for wildtype (n=6), 0.7315 ± 1.0806 for PIEZO1WT/M-R (n=5) and 
1.0305 ± 0.3489 for PIEZO1M-R/M-R (n=3). Although the data showed considerable variability, the 







Key points arising from this study are that: RBCs disable the rapid PIEZO1 inactivation seen in 
overexpression systems to reveal slower gating that is compatible with physiology; RBC PIEZO1 is 
activated by fluid flow; and the murine equivalent of the M2225R DHS mutation causes PIEZO1 
hyperactivity (gain-of-function) by disrupting deactivation. 
 
Inactivation and deactivation are distinct mechanisms: Inactivation is a type of desensitisation - channel 
closure despite continuous presence of the activation stimulus; while deactivation does not occur during 
continuous stimulation but only when the activation stimulus is removed. Some ion channels exhibit no 
inactivation, yet they still deactivate. Some are dominated by inactivation but are still capable of 
deactivation. A common important characteristic of inactivation is the depth of its associated closed 
state, which can result in slow recovery from inactivation and thus refractory periods that affect the 
frequency of events such as action potential firing. We know relatively little about the molecular 
mechanisms of inactivation and deactivation in PIEZO1 channels, but amino acid residues contributing 
to rapid inactivation have been suggested3 and our molecular dynamics simulations of PIEZO1 indicate 
how activation might occur4; opening the way to deactivation studies. Our data suggest that priorities 
for future PIEZO1 and PIEZO1-related DHS studies in RBCs should be the determination of how the 
rapid inactivation mechanism is disabled and how deactivation occurs at the molecular level. We 
studied only M2225R/M2241R, so it will be interesting to investigate other PIEZO1-related DHS 
mutations in the native RBC to see if deactivation is also relevant. 
 
Prior work indicated the mechanism of action of M2225R to be a subtle but significant slowing of the 
rate of rapid inactivation5-7 but our data suggest that such a rapid process (time constant ~10-ms) may 
not be physiologically relevant. We conclude that RBCs disable this rapid inactivation to reveal a much 
slower type of inactivation (at least 2 orders of magnitude slower) or that they greatly slow the rapid 
inactivation gate. We do not exclude importance of changes in inactivation in DHS because we observed 
very slow inactivation and M2241R slowed it further or abolished it, but M2241R-induced changes in 
deactivation were more striking. The removal of rapid inactivation exposes the additional deactivation 
feature. Disrupted deactivation theoretically creates a gain-of-function imbalance in which there is too 
much activation (opening) relative to deactivation (closing). Prior studies suggest that the threshold and 
rate of mechanical activation in M2225R is approximately the same as wildtype (i.e., suggesting no 
change in activation6,7) and our observations are consistent with this conclusion (Figure 1f-i). Therefore, 
an imbalance of activation/deactivation is likely and could cause problems for RBCs both in constant 
fluid flow and when flow is altered or stopped, as might occur for example in the spleen, vascular 
junctions with disturbed flow, a thrombus or a blood storage container. 
 
We consider it likely that RBC PIEZO1 channels sense fluid flow relatively directly. This suggestion 
is based primarily on studies of PIEZO1 in other cell types. In endothelium, where PIEZO1 is also 
functional, we observed robust PIEZO1 activation by fluid flow in excised membrane patches, 
suggesting a close relationship between PIEZO1 and flow8. In addition, by introducing exogenous 
PIEZO1, it has been possible to reconstitute fluid flow responses in HEK 293 cells that are otherwise 
resistant to fluid flow9-11. There is also independent evidence that PIEZO1 can be mechanically activated 
after reconstitution in an artificial lipid bilayer12 and that it curves the bilayer1. Nevertheless, it would 
be premature to conclude that PIEZO1 channels are directly activated by fluid flow in native systems 
such as RBCs because the flow may act via the lipid bilayer or other unknown proteins closely 
associated with PIEZO1. Indeed, we have noted previously that Ca2+ entry responses are not reliably 
reconstituted by PIEZO1 in all batches of HEK 293 cells and that this could potentially be explained 
by different batches of HEK 293 cells containing different amounts of a putative cofactor13. 
 
How M2225R/M2241R acts at the molecular level remains unknown. The mutation is in the C-terminal 
Extracellular Domain (CED) and so it is not immediately obvious how this might affect gating at the 
ion pore. But it is known that the CED has feet-like projections that make contact with the membrane-
spanning domains close to the ion pore region1. Therefore, conformation of CED may determine how 
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it interacts with the main body of PIEZO1 such that mutations affecting the dynamic structure of CED 
stabilise or destabilise the interaction and thus ion channel activity. Our data suggest that the switch to 
a positively charged amino acid residue is critical in conferring gain-of-function. A potential 
explanation is the formation of de novo inter- or intra-subunit salt bridges. Two acidic amino acid 
residues are close in the structure (E2236 and E2287 in mouse PIEZO1) and could enable a salt bridge 
effect. Our Yoda1-response data suggest that M2241A and M2241E do not confer gain-of-function. 
The data are consistent with a positive charge at this position (M2241R) enabling a salt bridge to form. 
Methionine (M), alanine (A) and glutamate (E) would not be compatible with such a bridge. This 
hypothesis would ideally be tested further in the overexpression system and through studies of 
mechanical activation of the endogenous channel. 
 
Overexpression techniques have led to the important conclusion that PIEZO1 forms mechanically-
activated channels14-16 and there is no reason to doubt this conclusion. Studies of native channels also 
suggest that PIEZO1 forms mechanically-activated channels, including those shown here and 
previously reported by us8,9 and other groups17-19. Therefore, overexpression studies have been, and 
remain, useful. However, it is emerging from studies of other non-RBC cells types that native 
environments profoundly alter PIEZO1 properties and particularly the extent of inactivation and its 
kinetics8,9,17,18,20,21. The relevant factors in native cells could include PIEZO1 density (i.e., PIEZO1 
channels affecting each other through proximity), local lipid constituents and associated protein factors 
such as cytoskeleton and other membrane proteins. Such factors might help explain why PIEZO1 
mutations associated with DHS apparently lead to such a restricted disease (i.e. only anaemia) when the 
gene is known to be widely expressed and functionally important14,16,22. 
 
GsMTx4 blocked the whole-cell depolarisation and inward current evoked by fluid flow and the single 
channel events activated by pressure pulses, consistent with them being mediated by PIEZO1 channels 
in both wildtype and mutant RBCs. GsMTx4 is not specific for PIEZO1 but does inhibit PIEZO1 
channels at the concentration we used23. It was notable that the responses in RBCs were sometimes 
reversed in polarity in the presence of GsMTx4. This could be explained if the mechanical stimulus 
also activates another ionic mechanism that opposes, but which is normally obscured by, the PIEZO1 
response. Further studies would be required to determine the identity of this mechanism. Previous 
studies have suggested that other channels are activated by fluid flow in RBCs24,25. 
 
We found that wash-out of GsMTx4 allowed recovery of activity and we prioritised study of these 
recovered responses in mutant RBCs. Intriguingly, the response became like that of wildtype RBCs in 
the absence of GsMTx4; i.e., there was deactivation, contrasting with the failed deactivation of mutant 
RBCs that are GsMTx4-naive. This suggests the possibility to pharmacologically revert mutant PIEZO1 
channels to wildtype behaviour. 
 
The exemplar pressure pulse data in Figure 2a show that relatively high pressure steps were sometimes 
needed to activate wildtype RBC PIEZO1 channels. However, in other patches we observed wildtype 
channels activated at -20 or -30 mmHg. These other data are not illustrated here but the whole-cell 
current data of Figure 1f-i do not suggest anything particularly different about the activation of wildtype 
and mutant channels. Single channel recordings necessarily display more variability than whole-cell 
recordings because of the smaller number of contributing unitary events. Large numbers of recordings 
would be needed to provide accurate estimates of pressure-activation curves from single channel data. 
 
Considerable variability occurs in the phenotype of DHS patients and it will be interesting to explore 
such phenotypes in detail in M2241R mice. Here the primary aim was determination of native channel 
gating principles. In terms of phenotyping we sought only indications of whether the mutant mice 
displayed some of the expected DHS characteristics. In part they matched the patient data, but in other 
regards they did not. However, we are cautious in the interpretation at this stage and do not overstress 
differences because most of our measurements were made in young adult mice, mostly at 8 weeks of 
age. We found that the spleen weight was unaffected at 8 weeks but increased at 22 weeks of age. This 
suggests that the exact phenotype may depend on age, and perhaps other factors such as environmental 
factors and diet. One expected phenotype is iron overload, reflecting abnormal iron homeostasis or 
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disturbed RBC development. At the 8-week time point, iron concentration and total iron-binding 
capacity (TIBC) were not significantly affected in M2241R mutant mice. It will be worth investigating 
if there are differences when the mice are older, consistent with prior work suggesting age-related 
changes in ferritin26. Pseudohyperkalemia with or without hematologic abnormalities is also observed 
in some patients, so this should also be investigated as the mice become older. Until such data are 
available it would be premature to make a detailed evaluation of the mutant mice as a model of the 
human disease. 
 
It is expected that individuals who are heterozygous for M2225R will have milder symptoms than 
individuals who are homozygous, and this was suggested in the initial discovery of this mutation27. 
However, the information available on these patients is relatively little and it would be premature to 
make a detail comparison of our observations on mice with patient data. Our data suggest that 
heterozygosity should cause intermediate phenotype, although the strength of the effect of 
heterozygosity on channel activity was impressive and close to homozygosity in many recordings, 
consistent with the view that heterozygosity is sufficient to cause DHS. 
 
The effects we observed could potentially be relevant to malarial resistance because a prior study 
suggested that the gain-of-function mutations R2482H in mouse (R2456H in DHS patients) and 
E756del (in as much as a third of African populations) may protect against malaria28. To the best of our 
knowledge this remains to be investigated for M2225R. Unexpectedly a subsequent study found no 
effect of E756del on RBC phenotype29, so further studies are needed to clarify the impact of this 
mutation. In overexpression experiments, E756del approximately doubled the amplitude of the response 
to high concentrations of Yoda1 but the effect on rapid inactivation was relatively small, although 
statistically significant28. It will be interesting to determine the effect of E756del on the 
electrophysiological properties of native PIEZO1 and its response to fluid flow. 
 
Our successful generation of a second mouse model of DHS (the first for M2225R) should be useful 
for further understanding DHS and developing therapeutic strategies to combat it. The first-published 
mouse model addressed the R2482H mutation28. Small-molecule activators of PIEZO1 are effective at 
mouse and human RBCs30,31 and could be tested in wildtype mice to see if malarial resistance can be 
achieved. Activators might also be useful in cases of loss-of-function PIEZO1 mutations that have been 
associated with non-immune hydrops fetalis and Generalised Lymphatic Dysplasia32,33. The available 
activator, Yoda1, exhibits relatively modest aqueous solubility34 and limited suitability for many in vivo 
applications and so should be considered as a tool compound for use only in specific situations. 
However, medicinal chemistry refinement of Yoda1 has been initiated35 and new activators may be 
discovered, paving the way for in vivo testing. If PIEZO1 inhibitors are discovered, they might be tested 
in M2241R mice for potential protection against anaemia because our GsMTx4 wash-out data suggest 
the possibility for correction of abnormal deactivation. The apparent external accessibility of 
M2225R/M2241R in the CED suggests that small-molecules or other agents could potentially be 




Murine PIEZO1 channel model Structural data were obtained from the mouse cryo-EM structure 
PDB: 6B3R1. Missing residues were added with MODELLER (v 9.19)36 and the loop refinement tool37 
was used to remove a knot in one chain between residues 1490-1498. The best loop was selected out of 
10 candidates according to the discrete optimized protein energy (DOPE) method38. The final PIEZO1 
mouse model does not comprises the first N-terminal 576 residues and residues 718-781, 1366-1492, 
1579-1654, 1808-1951. Therefore, each chain is composed by five non-overlapping fragments: residues 
577-717, 782-1365, 1493-1578, 1655-1807 and 1952-2547. The model obtained was further energy 
minimized in vacuum with GROMACS 5.0.739 and the CHARMM36 force field40. 
 
Human PIEZO1 channel model The human PIEZO1 protein sequence was obtained from the 
UniProtKB database (Universal Protein Resource Knowledgebase)41. The T-coffee method42 was used 
to obtain the final target-template alignment between the human and the mouse PIEZO1 sequences and 
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used in conjunction with MODELLER (v 9.19)36 to generate the initial human model. Unstructured 
residues 595-598, 881-884, 892-896, 1982-1998 and 2050-2058 from the initial human model were 
refined using the loop refinement tool37 from MODELLER and selecting the best loop out of 5 
candidates according the DOPE method38. The model obtained was further energy minimized in 
vacuum with GROMACS 5.0.739 and the CHARMM36 force field40. 
 
Generation of the PIEZO1 model mutants and molecular graphics The Dunbrack rotamer library 
43 implemented in UCSF Chimera (v 1.12)44 was used to generate the PIEZO1 model mutants of the 
M2225 and the M2241, for human and mouse respectively. Molecular graphics were generated using 
UCSF Chimera (v 1.12)44. 
 
Generation of PIEZO1M-R/M-R mice Mice were generated using CRISPR/Cas9 methodology. The 
guide RNA (gRNA) was designed to direct Cas9-mediated cleavage of PIEZO1 6-bp upstream of the 
target methionine codon with no off-target sites of less than 3 mismatches predicted elsewhere in the 
genome (binding sequence 5’ GGGCGCUCAUGGUGAACAG 3’). A 120 nucleotide single-stranded 
homology-directed repair (ssHDR) template was designed to incorporate the methionine to arginine 
missense mutation, in addition to silent mutations introducing a Mlu1 restriction enzyme recognition 
site to facilitate genotyping (5’ccacccgtcccctgagcctgaggggctccatg 
ctgagcgtgcttccatccccagccaTTAttTacGCGTagcgcccagcagccatccattgtgccattcacaccccaggcctacgaggag 3’; 
capital letters denote the mutated bases) (Sigma Aldrich). The gRNA, delivered as an alt-R crRNA 
combined with tracrRNA (Integrated DNA Technologies, Illnois, USA), Cas9 protein (New England 
Biolabs) and PAGE purified ssHDR template (Integrated DNA Technologies, Illnois, USA) were 
microinjected into C57BL/6 mouse zygotes and implanted in females (University of Manchester 
Transgenic unit). Successful gene editing of pups was identified by Mlu1 digestion of PCR amplicons 
(F: 5’ TCTGGTTCCCTCTGCTCTTC 3’, R: 5’ TGCCTTCGTGCCGTACTG 3’) and confirmed by 
DNA sequencing following sub-cloning into pCRTM-Blunt (Invitrogen). Further genotypes were 
determined by real-time PCR with specific probes designed for each gene (Transnetyx, Cordova, TN). 
All animal experiments were authorised by the University of Leeds Animal Ethics Committee and UK 
Home Office. Mice were housed in GM500 individually ventilated cages (Animal Care Systems) at 21 
°C, 50-70% humidity with a 12-hr alternating light/dark cycle. They had ad libitum access to RM1 diet 
(SpecialDiet Services) with bedding from Pure’o Cell (Datesand). Eight week-old male mice were used 
for experiments unless otherwise stated. 
 
Generation of PIEZO1 M2241 mutants Mouse PIEZO1 cDNA was cloned as described21. mPIEZO1 
mutants were made using site-directed mutagenesis using primers as follows: M2241R (F: 
CCACTGTTCACCAGGAGCGCCCAGCAG; R: CTGCTGGGCGCTCCTGGTGAACAGTGG). 
M2241K (F: GCCACTGTTCACCAAGAGCGCCCAGCAGC; R: 
GCTGCTGGGCGCTCTTGGTGAACAGTGGC). M2241A (F: 
GAGCCACTGTTCACCGCGAGCGCCCAGCAG; R: 
CTGCTGGGCGCTCGCGGTGAACAGTGGCTC). M2241E (F: 
GAGCCACTGTTCACCGAGAGCGCCCAGCAGC; R: 
GCTGCTGGGCGCTCTCGGTGAACAGTGGCTC). HEK-293 cells (Invitrogen) were transfected 
with 1 μg pcDNA4/TO-mPIEZO1/mPIEZO1M2241X (X: R, K, A or E) using Lipofectamine 2000 
(Invitrogen), 48 h prior to experiments. HEK-293 cells were maintained in DMEM supplemented with 
10% fetal calf serum and 1% penicillin/streptomycin (Sigma-Aldrich).   
Intracellular Ca2+ measurements HEK 293 cells were plated in poly-d-lysine coated 96-well plates 
(Corning, NY, USA) at a confluence of 90%, 24 h before experimentation. Cells were incubated with 
2 μM fura-2-AM (Molecular Probes™) in the presence of 0.01% pluronic acid (Thermo Fisher 
Scientific) in standard bath solution (SBS) for 1 h at 37 °C. Cells were washed with SBS for 30 min at 
room temperature. Measurements were made at room temperature on a 96-well fluorescence plate 
reader (FlexStation, Molecular Devices, Sunnyvale, CA, USA) controlled by Softmax Pro software 
v5.4.5. The change (Δ) in intracellular Ca2+ was indicated as the ratio of fura-2 emission (510 nm) 
intensities for 340 and 380 nm excitation. The SBS contained (mM): 130 NaCl, 5 KCl, 8 D-glucose, 10 




RBC fragility and other blood analysis Blood was diluted 1:8 into saline containing 2mM HEPES 
(pH 7.4). 10 μl of this diluted blood was added to each well on a row of a 96-well U-bottomed plate (8 
wells per sample). 225 μl tonicity solutions were added containing saline at concentrations of 0, 20, 25, 
30, 35, 40, 45, 50, 55, 60, 80 and 100%, made up in water. The plate was left at room temperature for 
5 min before centrifugation for 5 min at 1000xg. 150 μL of the supernatant was transferred into a well 
of a flat-bottomed 96-well clear plate. The absorbance was measured at 540 nm using a FlexStation 
(Molecular Devices). Haemotological properties of the mice were analysed by The Blood Sciences 
Laboratory, Leeds Teaching Hospitals, Leeds, UK. Full blood and reticulocyte counts were analysed 
by an ADVIA 2120i Haematology System. Samples were only analysed if hemolytic indices were 0 or 
+. Hemolysis indices were measured by Advia Chemistry XPT system. Border values were: 0 = 0 - 0.04 
g/dL; + = 0.05 - 0.13 g/dL; ++ = 0.14 - 0.23 g/dL; +++ = 0.24 - 0.44 g/dL; ++++ >= 0.45 g/dL. Blood 
smears were stained with May-Grunwald followed by Giesma and imaged by a Nikon Eclipse E400 
light microscope, fitted with a Nikon Digital Camera DXM1200. Liver function tests were analysed 
using an ADVIA Chemistry XPT System.  
 
Electron microscopy Clots for scanning electron microscopy (SEM) were prepared by adding 10 μL 
activation mixture (0.5 U.mL-1 murine thrombin [Enzyme Research Laboratories], CaCl2 5 mM in 
phosphate-buffered saline (PBS, pH 7.4)) to 100 μL of whole blood. The clotting mixture was 
immediately transferred to pierced Eppendorf lids. Clots were left to form in a humidified chamber at 
room temperature for 2 hr. Clots were washed with saline solution to remove excess salt and prepared 
for microscopy by fixation in 2% glutaraldehyde solution for at least 2 hr. Clots were further washed 
with sodium cacodylate buffer (67 mM C2H6AsNaO2, pH 7.4) and dehydrated in a series of increasing 
acetone concentrations (30%–100%). Clots were critical-point dried with CO2, mounted onto stubs, and 
sputter coated with platinum using a Cressington 208 HR (Cressington Scientific Instruments). Each 
clot was formed in duplicate and imaged in 5 areas at different magnifications (5000×, 10000×) using 
a Hitachi SU8230 high-performance cold field emission (CFE) SEM (Chiyoda). 
 
Isolation of RBCs for patch-clamp studies 500 L whole blood was collected in EDTA tubes and 
centrifuged at 10000g for 10 min at 4 °C. Plasma was removed and RBCs were washed twice with 1 
mL PBS followed by 1 min centrifugation under the same conditions. 2-μL of resulting haematocrit 
was resuspended in 5 mL PBS, plated onto borosilicate glass coverslips and left to settle for 30 min 
before recordings. 
 
Patch-clamp recordings Experiments were conducted in standard perforated-patch whole-cell 
(current- and voltage-clamp modes) and cell-attached (voltage-clamp) configurations. All recordings 
were made using AXOpatch 200B amplifier (Axon Instruments, Inc., USA) equipped with Digidata 
1550B hosted by a PC running pClamp 10.6 software (Molecular Devices, USA) at room temperature. 
Current records were analogue filtered at 2-5 kHz and digitally acquired at 5-20 kHz. Perforated-patch 
whole-cell transmembrane ionic currents were measured at a holding potential of −80 mV and cell-
attached experiments were performed at a holding potential of +80 mV. RBCs were maintained during 
the experiment in an external solution of the following composition (mM): 135 NaCl, 4 KCl, 2 CaCl2, 
1 MgCl2, 10 D-glucose and 10 HEPES (titrated to pH 7.4 with NaOH). 10 mM NaCl was equimolarly 
replaced with TEA-Cl in voltage-clamp experiments. Patch pipettes had a resistance of 20–25 MΩ when 
filled with pipette solution. The pipette solution for the perforated-patch whole-cell experiments 
contained (mM): 145 KCl, 1 MgCl2, 0.5 EGTA, 10 HEPES (titrated to pH 7.2 with KOH) and was 
supplemented with freshly prepared amphotericin B (300 µg.mL-1) before each experiment. For cell-
attached experiments the pipettes were filled with TEA-containing external solution. For application of 
fluid flow, membrane patches were manoeuvred to the exit of a capillary tube with tip diameter of 350 
μm, out of which ionic (bath) solution flowed at 20 μl.s-1. In pressure-clamp experiments 200-ms 
pressure steps from 0 to -90 mmHg, with 10 mmHg increments, were applied directly to the patch 
pipette with an interval of 12 s using High Speed Pressure Clamp HSPC-1 System (ALA Scientific 
Instruments, USA). In current-clamp experiments the resting membrane potential of RBCs was 
measured for 20 s before manually hyperpolarisation to -80 mV by current injection. The fluid flow 
was applied approximately 1 min after the new potential had been established and become stable. The 
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membrane potential exhibited greater random fluctuations at -80 mV compared with the resting 
potential (Supplemental Figure S13). Single channel current amplitudes were calculated from idealized 
traces using the 50 % threshold method in pClamp 10.7 software. Channel activity was expressed as 
NPo, as reported by pClamp 10.7 under Event Statistics following completion of the single-channel 
search procedure applied to idealized traces. Single-channel current amplitude histograms were plotted 
from the event data of the idealized traces with a 0.02 pA bin width. Amplitude histograms were fitted 
using Gaussian curves with peak values corresponding to channel open levels. Mean channel amplitudes 
at different membrane potentials were plotted and I–V relationships were fitted by linear regression 
with the gradient determining conductance value. 
 
Mouse transferrin ELISA Blood was harvested from anaesthetised mice by cardiac puncture in a 
EDTA coated tube (1.3-ml EDTA K3, Sarstedt) and centrifuged at 4000 rpm for 10 min. Plasma was 
aliquoted and stored at -80 °C. ELISA measuring plasma levels of Transferrin (Abcam ab157724) was 
quantified according to the manufacturer’s protocol. Assays were performed in duplicate and measured 
on microplate reader (FlexStation at 450nm). 
 
Data analysis Averaged data are presented as mean ± standard deviation (s.d.). For comparisons 
between two sets of data, Student’s t-tests were used. For multiple comparisons, one-way ANOVA was 
used with Bonferroni's post-hoc test. P < 0.05 was deemed significant (* <0.05, ** <0.01, *** <0.001). 
The genotypes of the mice were blinded to the experimental investigator. Data were analysed and 
plotted using pClamp 10.7 and Origin 2018 (OriginLab Corporation, USA). The letter n represents the 
number of independent biological experiments for a given result and is stated in the figure legends for 
each experiment. The number of independent repeats was at least 3. For multi-well plate assays, N is 







Figure S1. Mouse and human PIEZO1 are structurally similar. (a) Molecular models of human 
Piezo1 (left) and mouse Piezo1 (right). Each channel comprises three Piezo1 monomers, shown in 
different colors and ribbon representations (blue, orange, and pink for the human Piezo1 subunits; cyan, 
magenta, and light orange for the mouse Piezo1 subunits). The dashed black boxes indicate the regions 
of the C- terminal extracellular domain (CED) shown magnified in (b). (b) Each figure is a magnified 
view of all three Piezo1 monomers shown in (a) but focused on the structure at and around 
M2225/M2241 (wildtype human and mouse channels overlaid). M2225R is human Piezo1 in which 
methionine (M) is replaced by arginine (R) at position 2225. M2241A is mouse Piezo1 in which 
methionine (M) is replaced by alanine (A) at position 2241. M2241R is mouse Piezo1 in which 
methionine (M) is replaced by arginine (R) at position 2241. Atoms from each residue indicated above 





Figure S2. M2241R causes gain-of-function in mouse PIEZO1. (a) Exemplar intracellular Ca2+ 
measurement data for HEK 293 cells transiently transfected with wildtype (WT) murine PIEZO1 or 
PIEZO1 with the indicated mutations at position 2241. 30 s after the start of each recording, cells were 
exposed to 0.3 µM Yoda1. Ca2+ concentration is shown as increase above baseline (Ca2+i). Data are 
mean ± s.d (N=5 replicate wells were data point). (b) Summary analysis for experiments of the type 
shown in (a) in which responses to 0.3 µM Yoda1 or 1 µM Yoda1 were averaged over 30 s (30-60 s) 
after Yoda1 application. All individual data points are shown with mean ± s.d.: n = 4 (WT, M2241R, 
M2241K, M2241E) and n = 3 (M2241A). Statistical analysis was performed only on 0.3 M Yoda1 
data because all data were normalised to the WT 1 M Yoda1 response. One-way ANOVA with post 
hoc Bonferroni test indicated significantly increased response to 0.3 M Yoda1 in M2241R and 






Figure S3. Generation of PIEZO1M-R/M-R mice. (a) CRISPR mutagenesis design, gRNA target 
sequence indicated by arrow below the highlighted M2241, and ssODN donor template indicated by 
purple arrow above the sequence (upper panel). Post CRISPR mediated HDR the red sequence is 
integrated, resulting in synonymous base changes and non-synonymous base changes resulting in 
M2241R. Also indicated is the creation of a MluI restriction site. (b) MluI digest of PCR amplified 
products from gDNA extracted from pups. Dashed red boxes indicated candidate pups likely harbouring 
the desired change. (c) Sanger sequencing of pup 11 as an example, showing perfect alignment with 







Figure S4. Sequence analysis of PIEZO1M-R/M-R mouse colony. Sanger sequencing of PCR amplicon 
indicating CRISPR-generated mutations by homology-directed repair. DNA sequence encoding 
methionine (ATG) to arginine (CGT) mutation are highlighted by the blue box. Silent mutations for 
MLU1 selection are highlighted by the orange boxes. In the sequencing trace, blue = cysteine, green = 







Figure S5. Stomatocytosis. (a) RBCs from wildtype mice (WT, left) and PIEZO1M-R/M-R mice (right) 
were investigated with May-Grunwald and Giesma stains. Magnification was 100 times. The presence 
of stomatocytes is indicated by the black arrows in the PIEZO1M-R/M-R image. (b) Scanning electron 
microscopy images of RBCs from WT (1 example at 2 magnifications) and PIEZO1M-R/M-R (2 examples 
at 2 magnifications: “Piezo1 MR”) mice, showing presence of stomatocytes in PIEZO1M-R/M-R mice. 







Figure S6. Reduced osmotic fragility. (a) Osmotic fragility test in RBCs from WT, PIEZO1WT/M-R and 
PIEZO1M-R/M-R mice. Data are shown as mean ± s.d (n = 5, 6 and 5 respectively). (b) Analysis for data 
of the type shown in (a) to indicate the tonicity at which 50 % of the RBCs were lysed, calculated from 
fitted curves to each individual data set, as exemplified in (a). Each data point represents a value from 
an independent experiment with mean values and error bars representing s.d.. Statistical analysis was 






Figure S7. Increased spleen weight. (a) Mean ± s.d. weight of spleen as a percentage of total body 
weight in 8 week-old mice: n = 10 wildtype (WT) and n = 12 PIEZO1M-R/M-R. NS: not significantly 
different. (b) Mean ± s.d. weight of spleen as a percentage of total body weight in 22 week-old mice (n 






Figure S8. Birth numbers and weight gain in adults. (a) Numbers of mice born with the indicated 
genotypes after mating of PIEZO1WT/M-R mice. (b) Mean ± s.d. comparison of body weights of wildtype 






Figure S9. Effect of GsMTx4 on membrane potential responses. (a-c) Exemplar membrane potential 
(Vm) recordings obtained using perforated-patch whole-cell mode applied to freshly-isolated RBCs 
from wildtype (WT) (a), PIEZO1WT/M-R (b) or PIEZO1M-R/M-R mice (c) in the continuous presence of 2.5 
M GsMTx4. Mean data are shown in Figure 1e. (d, e) As for (b, c) but after at least 30 min wash-out 
of GsMTx4. (f) Mean ± s.d. data for experiments of the type shown in (d, e). All individual data points 
are superimposed. n = 6 (max, 1 min), 5 (2 and 3 min), 4 (4 and 5 min) for PIEZO1WT/M-R and n =5 for 
PIEZO1M-R/M-R. Statistical analysis by one-way ANOVA with Bonferroni's post-hoc test indicated 






Figure S10. Effect of GsMTx4 on membrane current responses. (a-c) Exemplar ionic current 
recordings obtained using perforated-patch technique in whole-cell voltage-clamp mode applied to 
freshly-isolated RBCs from wildtype (WT) (a), PIEZO1WT/M-R (b) or PIEZO1M-R/M-R mice (c) in the 
continuous presence of 2.5 M GsMTx4. Mean data are shown in Figure 1j. (d, e) As for (b, c) but after 
at least 30 min wash-out of GsMTx4. (f) Mean ± s.d. data for experiments of the type shown in (d, e). 
All individual data points are superimposed. n = 6 for PIEZO1WT/M-R and n = 5 (max, 1 min), 3 (2 min) 
for PIEZO1M-R/M-R. Statistical analysis by one-way ANOVA with Bonferroni's post-hoc test indicated 
significant decay of the PIEZO1WT/M-R and PIEZO1M-R/M-R responses at 1 and 2 min compared with Peak 







Figure S11. Unitary current-voltage (I-V) analysis. Single channel activity measured by cell-attached 
patch technique applied to freshly-isolated RBCs of PIEZO1WT/M-R mice. (a) Exemplar single channel 
activity at 5 voltages, as indicated to the left of each trace. Dotted horizontal lines indicate open (O) and 
closed (C) channel states. Activity was measured after a pressure pulse to -80 mmHg. (b) Mean ± s.d. 
unitary current amplitude plotted against voltage for 5 independent experiments. A straight line was 
fitted to each set of data points, indicating channel conductance of 25.3 ± 1.0 pS, which is the expected 






Figure S12. Single channel activity analysis. Single channel activity measured by cell-attached patch 
technique applied to freshly-isolated RBCs of wildtype (WT) (a), PIEZO1WT/M-R (b) or PIEZO1M-R/M-R 
mice (c, n=3) following pressure pulses to 0 - 90 mmHg for the full 12-s periods as exemplified in the 
traces of Figure 2a, c, e and g. Mean ± s.d. NPo (channel number multiplied by open probability) is 
plotted against the amplitude of the pressure pulse applied before measuring the activity. Statistical 
analysis by one-way ANOVA with Bonferroni's post-hoc test indicated significant increase in NPo of 
PIEZO1M-R/M-R but not WT or PIEZO1WT/M-R at 70, 80 and 90 mmHg compared with 0 mmHg (P ** 





Figure S13. Membrane potential setting to -80 mV. Exemplar measurement to illustrate the technical 
approach for membrane potential recordings. Shown are blocks of trace for the RBC resting membrane 
potential prior to current injection and the new membrane potential set to approximately -80 mV by 






Mean ± SD  
PIEZO1M-R/M-R 
Mean ± SD (P value vs WT)  
HGB (g/L) 129.60 ± 2.30 
  
121.50 ± 2.65 (0.002**) 
  
WBC (109 cells/L) 2.50 ± 0.61 
  
2.945 ± 1.20 (0.50) 
  
WBCP (109 cells/L) 2.39 ± 0.52 
  
2.81 ± 1.24 (0.50) 
  
PLT (109 cells/L) 861.20 ± 108.66 861.5 ± 106.83 (0.99) 
  
MCV (fL) 50.64 ± 0.95 
  
49.90 ± 1.08 (0.31) 
  
HCT (L/L) 0.45 ± 0.01 
  
0.41 ± 0.01 (0.003**)  
RBC (1012 cells/L) 8.88 ± 0.14 
  
8.32 ± 0.43 (0.03*) 
  
MCH (pg) 14.60 ± 0.19 
  
14.63 ± 0.74 (0.94) 
  
MCHC (g/L) 288.24 ± 8.28 
  
293.18 ± 10.51 (0.45) 
  
CHCM (g/L) 282.40 ± 8.91 292.50 ± 9.15 (0.14) 
RDW (%) 11.74 ± 0.27 14.18 ± 0.43 (0.00002***) 
HDW (g/L) 16.56 ± 0.98 
  
19.40 ± 1.31 (0.007**) 
  
%RETIC 4.27 ± 0.79 7.33 ± 0.78 (0.002**) 
 
 
Table S1. Haematological parameters. Mean ± s.d. data and p-values for haematological parameters 
comparing WT (n = 4) and PIEZO1M-R/M-R (n = 5) mice: HGB, Haemoglobin; WBC, White blood cells; 
WBCP, White Blood Cell Count from the Peroxidase Method; PLT, Platelet Count; MCV, Mean 
Corpuscular Volume; HCT, Haematocrit; RBC, Red Blood Cells; MCH, Mean Corpuscular 
Haemoglobin; MCHC, Mean Corpuscular Haemoglobin Concentration; CHCM, Cellular Haemoglobin 
Concentration Mean; RDW, Red Blood Cell Distribution Width; HDW, Haemoglobin Concentration 
Distribution Width; %RETIC, percentage of reticulocytes. Statistically significant differences are 









13.04 ± 1.65 
  






146.68 ± 22.23 
  






33.84 ± 7.14 
  






18.98 ± 3.61 
  






21.72 ± 27.66† 38.46 ± 29.98 0.39 
Transferrin (mg/mL) 2.22 ± 0.18 2.56 ± 0.27 0.0051* 
 
 
Table S2. Liver function and iron tests. Liver function tests: ALBP, albumin; ALP-2c, alkaline 
phosphatase; ALT-c, alanine aminotransferase; TIBC, total iron binding capacity. Data are shown as 
mean ± s.d. (n = 5 mice in each group except for the transferrin data, which are for n = 8 WT mice and 
n = 12 PIEZO1M-R/M-R mice). †The analysis included 3 values that could only be determined as <8.4 
Mol/L and the number 8.4 was used (see Source Data). Statistically significant differences are 
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